BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16923985)

  • 1. A modified procedure for transjugular intrahepatic portosystemic shunt flow reduction.
    Jacquier A; Vidal V; Monnet O; Varoquaux A; Gaubert JY; Champsaur P; Gerolami R; Bartoli JM; Moulin G
    J Vasc Interv Radiol; 2006 Aug; 17(8):1359-63. PubMed ID: 16923985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
    Maleux G; Heye S; Verslype C; Nevens F
    J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel endovascular adjustable polytetrafluoroethylene-covered stent for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Weintraub JL; Mobley DG; Weiss ME; Swanson E; Kothary N
    J Vasc Interv Radiol; 2007 Apr; 18(4):563-6. PubMed ID: 17446548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts.
    Maleux G; Verslype C; Heye S; Wilms G; Marchal G; Nevens F
    AJR Am J Roentgenol; 2007 Mar; 188(3):659-64. PubMed ID: 17312051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents.
    Pan JJ; Chen C; Geller B; Firpi R; Machicao VI; Caridi JG; Nelson DR; Morelli G
    Clin Radiol; 2008 Oct; 63(10):1142-8. PubMed ID: 18774362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
    Rössle M; Siegerstetter V; Euringer W; Olschewski M; Kromeier J; Kurz K; Langer M
    Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent-graft narrowed with a lasso catheter: an adjustable TIPS reduction technique.
    Monnin-Bares V; Thony F; Sengel C; Bricault I; Leroy V; Ferretti G
    J Vasc Interv Radiol; 2010 Feb; 21(2):275-80. PubMed ID: 20123211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.
    Cejna M; Peck-Radosavljevic M; Thurnher S; Schoder M; Rand T; Angermayr B; Lammer J
    Cardiovasc Intervent Radiol; 2002; 25(5):365-72. PubMed ID: 11981612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: outcomes of a retrospective case series.
    Cookson DT; Zaman Z; Gordon-Smith J; Ireland HM; Hayes PC
    Cardiovasc Intervent Radiol; 2011 Feb; 34(1):92-9. PubMed ID: 21057793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and Occlusion.
    Taylor AG; Kolli KP; Kerlan RK
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):74-81. PubMed ID: 26997091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt flow reduction with adjustable polytetrafluoroethylene-covered balloon-expandable stents.
    Kroma G; Lopera J; Cura M; Suri R; El-Merhi F; Reading J
    J Vasc Interv Radiol; 2009 Jul; 20(7):981-6. PubMed ID: 19497763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft.
    Fanelli F; Salvatori FM; Rabuffi P; Boatta E; Riggio O; Lucatelli P; Passariello R
    AJR Am J Roentgenol; 2009 Dec; 193(6):1696-702. PubMed ID: 19933667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
    Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.